20030304
 ImClone Says Fazio Is Joining Its Board As Ringrose Leaves   The Wall Street Journal,  Mar 5, 2003  An investigation continues into trading of ImClone shares in late December 2001 shortly before the U.S. Food and Drug Administration rejected the company's application for cancer drug Erbitux. ImClone founder and former Chief Executive Samuel Waksal pleaded guilty to insider trading last year, and Monday pleaded guilty to two charges related to evading taxes on art purchases in 2000 and 2001. Mr. Waksal's friend Martha Stewart, the homemaking guru, remains under investigation.   
